Completed
Efficacy and Safety of Increased Dose of TA-650 (Infliximab) in Patients With Crohn's Disease (CD)
NCT00805766
- Conditions
- Crohn Disease, Crohn's Disease, Digestive System Diseases, +4 more
- Locations
-
- Investigational site Hokkaido, Japan
- Investigational site Kansai, Japan
- Investigational site Kanto, Japan
- Investigational site Kyushu, Japan